Interventional Neurology Devices - Global Market Outlook (2017-2023)

  • ID: 4426426
  • Report
  • Region: Global
  • 166 pages
  • Stratistics Market Research Consulting Pvt Ltd
UP TO OFF
until Jan 31st 2019
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1 of 4

FEATURED COMPANIES

  • Abbott
  • Acandis
  • B. Braun Melsungen
  • Bayer
  • Biosensors International
  • Boston Scientific
  • MORE
According to MRC,the Global Interventional Neurology Devices Market accounted for $1.89 billion in 2016 and expected to grow at a CAGR of 10.3% to reach $3.76 billion by 2023. The market factors such as growth due to obesity and aged population, rising frequency for hemorrhagic and ischemic stroke, ongoing product development and commercialization, expansion of healthcare infrastructure across emerging markets are propelling the market growth. However, stringent regulations and lack of talented neurologists are restraining the market growth. Increasing research activities in the field of neurovascular therapies, demand for minimally invasive neurosurgical procedures and surgeon’s awareness related to benefits of stereotactic framework procedures in neurosurgeries are creating wider opportunities for the market growth.

Cerebral arteriovenous malformations and dural arteriovenous fistulas (DAVFs) require complex treatment. The endovascular treatment with embolization is a fundamental component of the multidisciplinary management, together with radiosurgery and surgery. Microsurgery (ie, craniotomy followed by resection) has been reported to have a low risk of complications for in SMG I and II brain AVMs. Ischaemic strokes are caused by a blockage cutting off the blood supply to the brain. The blockage can be caused by a blood clot forming in an artery leading to the brain or within one of the small vessels deep inside the brain. Trials namely the ESCAPE, SWIFT PRIME, and EXTEND-IA studies als-proved the effectiveness of mechanical thrombectomy in large vessel occlusion.

At present, Food and Drug Administration (FDA) approved the Pipeline embolization device (PED; Medtronic) for use in anterior circulation aneurysms. Presently, PED and its second generation, the Pipeline Flex, are the only flow diverters available in the United States. Internationally, the Silk device (Balt Extrusion), p64 flow modulation device (phenox GmbH), Flow Re-direction Endoluminal Device (FRED; MicroVention Terumo), and Surpass device (Stryker) are available. New coils, both pushable and detachable, have als-recently been developed. The use of detachable coils with different lengths and volumes is on the rise, and a new coil without a metallic frame has als-arrived to the market. The use of liquid embolic materials is increasing in peripheral applications. New materials are in the pipeline. For example, Squid is a non adhesive liquid embolic agent for embolization of brain Arteriovenous Malformations (AVM). It is composed of EVOH (ethylene vinyl alcohol copolymer) with suspended micronized Tantalum powder for radiopacity and DMS-(dimethyl sulfoxide) solvent. Squid must be injected through a DMS-compatible microcatheter.

Recently clot retrieval devices were approved by the FDA as firsto line treatment along with IV rto PA. The Penumbra Aspiration System, EmboTrap(®)II, stent retrievers, have the FDA clearance as firsto line treatment for acute ischemic stroke along with IV rto PA. Neurothrombectomy devices offer many potential advantages over pharmacologic thrombolysis, including more rapid achievement of recanalization, enhanced efficacy in treating large-vessel occlusions, and a potentially lower risk for hemorrhagic events. Currently, tw-neurothrombectomy devices are cleared by the U.S. Food and Drug Administration (FDA) through its 510(k) process: the MERCI Retriever (Concentric Medical) and the Penumbra System.

North America is expected to dominate the market owing to adoption of neurovascular devices among neurosurgeons in neurovascular disease treatment, growing number of clinical trials and significant medical reimbursement available in the U.S. for neurosurgical procedures.

The key players in Global Interventional Neurology Devices market are Abbott, Medtronic, Stryker, TERUMO, Acandis, B. Braun Melsungen, Bayer, Boston Scientific, Biosensors International, Covidien PLC, Integra LifeSciences Holdings Corporation, St. Jude Medical, Inc, W.L. Gore & Associates, Inc. and Magstim C-Ltd.

Applications Covered:
  • Arteriovenous Malformation and Fistulas
  • Cerebral Aneurysms
  • Schemic Strokes
  • Intracranial Atherosclerotic Disease
Products Covered:
  • Carotid Artery Angioplasty and Stenting
  • Carotid Artery Stents
  • Embolic Protection Systems
  • Balloon Occlusion Devices
  • Aneurysm Coiling and Embolization Devices
  • Flow Diversion Devices
  • Liquid Embolic Devices
  • Embolic coils
  • Micr-Support Devices
  • Microcatheters
  • Microguidewires
  • Neurothrombectomy
  • Suction and Aspiration Devices
  • Snares
  • Clot Retrieval Devices
Techniques Covered:
  • Angioplasty & Stenting
  • Neurothrombectomy
  • Pre-operative Tumor Embolization
  • Vertebroplasty
  • Stroke Therapy
End Users Covered:
  • Ambulatory Care Centers
  • Hospitals
  • Neurology Clinics
Regions Covered:
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
  • South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa
What The Report Offers:
  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • Acandis
  • B. Braun Melsungen
  • Bayer
  • Biosensors International
  • Boston Scientific
  • MORE
1. Executive Summary

2. Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3. Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Futuristic Market Scenario

4. Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5. Global Interventional Neurology Devices Market, By Application
5.1 Introduction
5.2 Arteriovenous Malformation and Fistulas
5.3 Cerebral Aneurysms
5.4 Schemic Strokes
5.5 Intracranial Atherosclerotic Disease

6. Global Interventional Neurology Devices Market, By Product
6.1 Introduction
6.2 Carotid Artery Angioplasty and Stenting
6.2.1 Carotid Artery Stents
6.2.2 Embolic Protection Systems
6.2.3 Balloon Occlusion Devices
6.3 Aneurysm Coiling and Embolization Devices
6.3.1 Flow Diversion Devices
6.3.2 Liquid Embolic Devices
6.3.3 Embolic coils
6.3.3.1 Coated Detachable Coils
6.3.3.2 Bare Detachable Coils
6.4 Micro Support Devices
6.4.1 Microcatheters
6.4.2 Microguidewires
6.5 Neurothrombectomy
6.5.1 Suction and Aspiration Devices
6.5.2 Snares
6.5.3 Clot Retrieval Devices

7. Global Interventional Neurology Devices Market, By Technique
7.1 Introduction
7.2 Angioplasty & Stenting
7.3 Neurothrombectomy
7.4 Pre-operative Tumor Embolization
7.5 Vertebroplasty
7.6 Stroke Therapy

8. Global Interventional Neurology Devices Market, By End User
8.1 Introduction
8.2 Ambulatory Care Centers
8.3 Hospitals
8.4 Neurology Clinics

9. Global Interventional Neurology Devices Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa

10. Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11. Company Profiling
11.1 Abbott
11.2 Medtronic
11.3 Stryker
11.4 TERUMO
11.5 Acandis
11.6 B. Braun Melsungen
11.7 Bayer
11.8 Boston Scientific
11.9 Biosensors International
11.10 Covidien PLC
11.11 Integra LifeSciences Holdings Corporation
11.12 St. Jude Medical, Inc
11.13 W.L. Gore & Associates, Inc.
11.14 Magstim Co Ltd.

List of Tables

Table 1 Global Interventional Neurology Devices Market Outlook, By Region (2014-2023) ($MN)
Table 2 Global Interventional Neurology Devices Market Outlook, By Application (2014-2023) ($MN)
Table 3 Global Interventional Neurology Devices Market Outlook, By Arteriovenous Malformation and Fistulas (2014-2023) ($MN)
Table 4 Global Interventional Neurology Devices Market Outlook, By Cerebral Aneurysms (2014-2023) ($MN)
Table 5 Global Interventional Neurology Devices Market Outlook, By Schemic Strokes (2014-2023) ($MN)
Table 6 Global Interventional Neurology Devices Market Outlook, By Intracranial Atherosclerotic Disease (2014-2023) ($MN)
Table 7 Global Interventional Neurology Devices Market Outlook, By Product (2014-2023) ($MN)
Table 8 Global Interventional Neurology Devices Market Outlook, By Carotid Artery Angioplasty and Stenting (2014-2023) ($MN)
Table 9 Global Interventional Neurology Devices Market Outlook, By Carotid Artery Stents (2014-2023) ($MN)
Table 10 Global Interventional Neurology Devices Market Outlook, By Embolic Protection Systems (2014-2023) ($MN)
Table 11 Global Interventional Neurology Devices Market Outlook, By Balloon Occlusion Devices (2014-2023) ($MN)
Table 12 Global Interventional Neurology Devices Market Outlook, By Aneurysm Coiling and Embolization Devices (2014-2023) ($MN)
Table 13 Global Interventional Neurology Devices Market Outlook, By Flow Diversion Devices (2014-2023) ($MN)
Table 14 Global Interventional Neurology Devices Market Outlook, By Liquid Embolic Devices (2014-2023) ($MN)
Table 15 Global Interventional Neurology Devices Market Outlook, By Embolic coils (2014-2023) ($MN)
Table 16 Global Interventional Neurology Devices Market Outlook, By Micro Support Devices (2014-2023) ($MN)
Table 17 Global Interventional Neurology Devices Market Outlook, By Microcatheters (2014-2023) ($MN)
Table 18 Global Interventional Neurology Devices Market Outlook, By Microguidewires (2014-2023) ($MN)
Table 19 Global Interventional Neurology Devices Market Outlook, By Neurothrombectomy (2014-2023) ($MN)
Table 20 Global Interventional Neurology Devices Market Outlook, By Suction and Aspiration Devices (2014-2023) ($MN)
Table 21 Global Interventional Neurology Devices Market Outlook, By Snares (2014-2023) ($MN)
Table 22 Global Interventional Neurology Devices Market Outlook, By Clot Retrieval Devices (2014-2023) ($MN)
Table 23 Global Interventional Neurology Devices Market Outlook, By Technique (2014-2023) ($MN)
Table 24 Global Interventional Neurology Devices Market Outlook, By Angioplasty & Stenting (2014-2023) ($MN)
Table 25 Global Interventional Neurology Devices Market Outlook, By Neurothrombectomy (2014-2023) ($MN)
Table 26 Global Interventional Neurology Devices Market Outlook, By Pre-operative Tumor Embolization (2014-2023) ($MN)
Table 27 Global Interventional Neurology Devices Market Outlook, By Vertebroplasty (2014-2023) ($MN)
Table 28 Global Interventional Neurology Devices Market Outlook, By Stroke Therapy (2014-2023) ($MN)
Table 29 Global Interventional Neurology Devices Market Outlook, By End User (2014-2023) ($MN)
Table 30 Global Interventional Neurology Devices Market Outlook, By Ambulatory Care Centers (2014-2023) ($MN)
Table 31 Global Interventional Neurology Devices Market Outlook, By Hospitals (2014-2023) ($MN)
Table 32 Global Interventional Neurology Devices Market Outlook, By Neurology Clinics (2014-2023) ($MN)
Table 33 North America Interventional Neurology Devices Market Outlook, By Country (2014-2023) ($MN)
Table 34 North America Interventional Neurology Devices Market Outlook, By Application (2014-2023) ($MN)
Table 35 North America Interventional Neurology Devices Market Outlook, By Arteriovenous Malformation and Fistulas (2014-2023) ($MN)
Table 36 North America Interventional Neurology Devices Market Outlook, By Cerebral Aneurysms (2014-2023) ($MN)
Table 37 North America Interventional Neurology Devices Market Outlook, By Schemic Strokes (2014-2023) ($MN)
Table 38 North America Interventional Neurology Devices Market Outlook, By Intracranial Atherosclerotic Disease (2014-2023) ($MN)
Table 39 North America Interventional Neurology Devices Market Outlook, By Product (2014-2023) ($MN)
Table 40 North America Interventional Neurology Devices Market Outlook, By Carotid Artery Angioplasty and Stenting (2014-2023) ($MN)
Table 41 North America Interventional Neurology Devices Market Outlook, By Carotid Artery Stents (2014-2023) ($MN)
Table 42 North America Interventional Neurology Devices Market Outlook, By Embolic Protection Systems (2014-2023) ($MN)
Table 43 North America Interventional Neurology Devices Market Outlook, By Balloon Occlusion Devices (2014-2023) ($MN)
Table 44 North America Interventional Neurology Devices Market Outlook, By Aneurysm Coiling and Embolization Devices (2014-2023) ($MN)
Table 45 North America Interventional Neurology Devices Market Outlook, By Flow Diversion Devices (2014-2023) ($MN)
Table 46 North America Interventional Neurology Devices Market Outlook, By Liquid Embolic Devices (2014-2023) ($MN)
Table 47 North America Interventional Neurology Devices Market Outlook, By Embolic coils (2014-2023) ($MN)
Table 48 North America Interventional Neurology Devices Market Outlook, By Micro Support Devices (2014-2023) ($MN)
Table 49 North America Interventional Neurology Devices Market Outlook, By Microcatheters (2014-2023) ($MN)
Table 50 North America Interventional Neurology Devices Market Outlook, By Microguidewires (2014-2023) ($MN)
Table 51 North America Interventional Neurology Devices Market Outlook, By Neurothrombectomy (2014-2023) ($MN)
Table 52 North America Interventional Neurology Devices Market Outlook, By Suction and Aspiration Devices (2014-2023) ($MN)
Table 53 North America Interventional Neurology Devices Market Outlook, By Snares (2014-2023) ($MN)
Table 54 North America Interventional Neurology Devices Market Outlook, By Clot Retrieval Devices (2014-2023) ($MN)
Table 55 North America Interventional Neurology Devices Market Outlook, By Technique (2014-2023) ($MN)
Table 56 North America Interventional Neurology Devices Market Outlook, By Angioplasty & Stenting (2014-2023) ($MN)
Table 57 North America Interventional Neurology Devices Market Outlook, By Neurothrombectomy (2014-2023) ($MN)
Table 58 North America Interventional Neurology Devices Market Outlook, By Pre-operative Tumor Embolization (2014-2023) ($MN)
Table 59 North America Interventional Neurology Devices Market Outlook, By Vertebroplasty (2014-2023) ($MN)
Table 60 North America Interventional Neurology Devices Market Outlook, By Stroke Therapy (2014-2023) ($MN)
Table 61 North America Interventional Neurology Devices Market Outlook, By End User (2014-2023) ($MN)
Table 62 North America Interventional Neurology Devices Market Outlook, By Ambulatory Care Centers (2014-2023) ($MN)
Table 63 North America Interventional Neurology Devices Market Outlook, By Hospitals (2014-2023) ($MN)
Table 64 North America Interventional Neurology Devices Market Outlook, By Neurology Clinics (2014-2023) ($MN)
Table 65 Europe Interventional Neurology Devices Market Outlook, By Country (2014-2023) ($MN)
Table 66 Europe Interventional Neurology Devices Market Outlook, By Application (2014-2023) ($MN)
Table 67 Europe Interventional Neurology Devices Market Outlook, By Arteriovenous Malformation and Fistulas (2014-2023) ($MN)
Table 68 Europe Interventional Neurology Devices Market Outlook, By Cerebral Aneurysms (2014-2023) ($MN)
Table 69 Europe Interventional Neurology Devices Market Outlook, By Schemic Strokes (2014-2023) ($MN)
Table 70 Europe Interventional Neurology Devices Market Outlook, By Intracranial Atherosclerotic Disease (2014-2023) ($MN)
Table 71 Europe Interventional Neurology Devices Market Outlook, By Product (2014-2023) ($MN)
Table 72 Europe Interventional Neurology Devices Market Outlook, By Carotid Artery Angioplasty and Stenting (2014-2023) ($MN)
Table 73 Europe Interventional Neurology Devices Market Outlook, By Carotid Artery Stents (2014-2023) ($MN)
Table 74 Europe Interventional Neurology Devices Market Outlook, By Embolic Protection Systems (2014-2023) ($MN)
Table 75 Europe Interventional Neurology Devices Market Outlook, By Balloon Occlusion Devices (2014-2023) ($MN)
Table 76 Europe Interventional Neurology Devices Market Outlook, By Aneurysm Coiling and Embolization Devices (2014-2023) ($MN)
Table 77 Europe Interventional Neurology Devices Market Outlook, By Flow Diversion Devices (2014-2023) ($MN)
Table 78 Europe Interventional Neurology Devices Market Outlook, By Liquid Embolic Devices (2014-2023) ($MN)
Table 79 Europe Interventional Neurology Devices Market Outlook, By Embolic coils (2014-2023) ($MN)
Table 80 Europe Interventional Neurology Devices Market Outlook, By Micro Support Devices (2014-2023) ($MN)
Table 81 Europe Interventional Neurology Devices Market Outlook, By Microcatheters (2014-2023) ($MN)
Table 82 Europe Interventional Neurology Devices Market Outlook, By Microguidewires (2014-2023) ($MN)
Table 83 Europe Interventional Neurology Devices Market Outlook, By Neurothrombectomy (2014-2023) ($MN)
Table 84 Europe Interventional Neurology Devices Market Outlook, By Suction and Aspiration Devices (2014-2023) ($MN)
Table 85 Europe Interventional Neurology Devices Market Outlook, By Snares (2014-2023) ($MN)
Table 86 Europe Interventional Neurology Devices Market Outlook, By Clot Retrieval Devices (2014-2023) ($MN)
Table 87 Europe Interventional Neurology Devices Market Outlook, By Technique (2014-2023) ($MN)
Table 88 Europe Interventional Neurology Devices Market Outlook, By Angioplasty & Stenting (2014-2023) ($MN)
Table 89 Europe Interventional Neurology Devices Market Outlook, By Neurothrombectomy (2014-2023) ($MN)
Table 90 Europe Interventional Neurology Devices Market Outlook, By Pre-operative Tumor Embolization (2014-2023) ($MN)
Table 91 Europe Interventional Neurology Devices Market Outlook, By Vertebroplasty (2014-2023) ($MN)
Table 92 Europe Interventional Neurology Devices Market Outlook, By Stroke Therapy (2014-2023) ($MN)
Table 93 Europe Interventional Neurology Devices Market Outlook, By End User (2014-2023) ($MN)
Table 94 Europe Interventional Neurology Devices Market Outlook, By Ambulatory Care Centers (2014-2023) ($MN)
Table 95 Europe Interventional Neurology Devices Market Outlook, By Hospitals (2014-2023) ($MN)
Table 96 Europe Interventional Neurology Devices Market Outlook, By Neurology Clinics (2014-2023) ($MN)
Table 97 Asia Pacific Interventional Neurology Devices Market Outlook, By Country (2014-2023) ($MN)
Table 98 Asia Pacific Interventional Neurology Devices Market Outlook, By Application (2014-2023) ($MN)
Table 99 Asia Pacific Interventional Neurology Devices Market Outlook, By Arteriovenous Malformation and Fistulas (2014-2023) ($MN)
Table 100 Asia Pacific Interventional Neurology Devices Market Outlook, By Cerebral Aneurysms (2014-2023) ($MN)
Table 101 Asia Pacific Interventional Neurology Devices Market Outlook, By Schemic Strokes (2014-2023) ($MN)
Table 102 Asia Pacific Interventional Neurology Devices Market Outlook, By Intracranial Atherosclerotic Disease (2014-2023) ($MN)
Table 103 Asia Pacific Interventional Neurology Devices Market Outlook, By Product (2014-2023) ($MN)
Table 104 Asia Pacific Interventional Neurology Devices Market Outlook, By Carotid Artery Angioplasty and Stenting (2014-2023) ($MN)
Table 105 Asia Pacific Interventional Neurology Devices Market Outlook, By Carotid Artery Stents (2014-2023) ($MN)
Table 106 Asia Pacific Interventional Neurology Devices Market Outlook, By Embolic Protection Systems (2014-2023) ($MN)
Table 107 Asia Pacific Interventional Neurology Devices Market Outlook, By Balloon Occlusion Devices (2014-2023) ($MN)
Table 108 Asia Pacific Interventional Neurology Devices Market Outlook, By Aneurysm Coiling and Embolization Devices (2014-2023) ($MN)
Table 109 Asia Pacific Interventional Neurology Devices Market Outlook, By Flow Diversion Devices (2014-2023) ($MN)
Table 110 Asia Pacific Interventional Neurology Devices Market Outlook, By Liquid Embolic Devices (2014-2023) ($MN)
Table 111 Asia Pacific Interventional Neurology Devices Market Outlook, By Embolic coils (2014-2023) ($MN)
Table 112 Asia Pacific Interventional Neurology Devices Market Outlook, By Micro Support Devices (2014-2023) ($MN)
Table 113 Asia Pacific Interventional Neurology Devices Market Outlook, By Microcatheters (2014-2023) ($MN)
Table 114 Asia Pacific Interventional Neurology Devices Market Outlook, By Microguidewires (2014-2023) ($MN)
Table 115 Asia Pacific Interventional Neurology Devices Market Outlook, By Neurothrombectomy (2014-2023) ($MN)
Table 116 Asia Pacific Interventional Neurology Devices Market Outlook, By Suction and Aspiration Devices (2014-2023) ($MN)
Table 117 Asia Pacific Interventional Neurology Devices Market Outlook, By Snares (2014-2023) ($MN)
Table 118 Asia Pacific Interventional Neurology Devices Market Outlook, By Clot Retrieval Devices (2014-2023) ($MN)
Table 119 Asia Pacific Interventional Neurology Devices Market Outlook, By Technique (2014-2023) ($MN)
Table 120 Asia Pacific Interventional Neurology Devices Market Outlook, By Angioplasty & Stenting (2014-2023) ($MN)
Table 121 Asia Pacific Interventional Neurology Devices Market Outlook, By Neurothrombectomy (2014-2023) ($MN)
Table 122 Asia Pacific Interventional Neurology Devices Market Outlook, By Pre-operative Tumor Embolization (2014-2023) ($MN)
Table 123 Asia Pacific Interventional Neurology Devices Market Outlook, By Vertebroplasty (2014-2023) ($MN)
Table 124 Asia Pacific Interventional Neurology Devices Market Outlook, By Stroke Therapy (2014-2023) ($MN)
Table 125 Asia Pacific Interventional Neurology Devices Market Outlook, By End User (2014-2023) ($MN)
Table 126 Asia Pacific Interventional Neurology Devices Market Outlook, By Ambulatory Care Centers (2014-2023) ($MN)
Table 127 Asia Pacific Interventional Neurology Devices Market Outlook, By Hospitals (2014-2023) ($MN)
Table 128 Asia Pacific Interventional Neurology Devices Market Outlook, By Neurology Clinics (2014-2023) ($MN)
Table Note: South America and Middle East & Africa are represented in above manner.
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott
  • Medtronic
  • Stryker
  • TERUMO
  • Acandis
  • B. Braun Melsungen
  • Bayer
  • Boston Scientific
  • Biosensors International
  • Covidien PLC
  • Integra LifeSciences Holdings Corporati
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll